Patients devastated by HSE decision not to fund treatment for rare genetic disease

Patients suffering from a rare genetic disease say they are devastated that the HSE has decided not to fund a new treatment for the condition.

Patients devastated by HSE decision not to fund treatment for rare genetic disease

Patients suffering from a rare genetic disease say they are devastated that the HSE has decided not to fund a new treatment for the condition.

The decision affects 60 patients who suffer from Alpha 1 - a genetic form of Emphysema.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited